PPARGC1A and Insulin resistance: Given that PGC-1α has been shown to alleviate insulin resistance and oxidative stress, as well as to reduce amyloid plaque accumulation [34,37], its upregulation may underlie, at least in part, the reduction in amyloid plaque burden observed in NC-treated animals.